Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Basic 3-hydroxypyridin-4-ones: potential antimalarial agents.

Lotfollah S Dehkordi1, Zu D Liu, Robert C Hider

  • 1School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.

European Journal of Medicinal Chemistry
|September 18, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiotracers for in situ infection imaging: Experimental considerations for in vitro microbial uptake of gallium-68-labeled siderophores.

Diagnostic microbiology and infectious disease·2024
Same author

[<sup>68</sup>Ga]Ga-Schizokinen, a Potential Radiotracer for Selective Bacterial Infection Imaging.

ACS infectious diseases·2024
Same author

The iron(III) coordinating properties of citrate and α-hydroxycarboxylate containing siderophores.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine·2024
Same author

The Colorimetric Detection of the Hydroxyl Radical.

International journal of molecular sciences·2023
Same author

Targeting integrin αvβ6 with gallium-68 tris (hydroxypyridinone) based PET probes.

Dalton transactions (Cambridge, England : 2003)·2022
Same author

PSMA-targeted NIR probes for image-guided detection of prostate cancer.

Colloids and surfaces. B, Biointerfaces·2022

New 3-hydroxypyridin-4-one compounds show improved antimalarial activity. These molecules target acidic cellular compartments, offering potential for enhanced treatment of malaria without mammalian cell toxicity.

Area of Science:

  • Medicinal Chemistry
  • Parasitology
  • Pharmacology

Background:

  • 3-Hydroxypyridin-4-ones are known iron chelators with applications in treating iron overload disorders like thalassaemia.
  • Related compounds exhibit non-toxic antimalarial effects in mammalian cells.

Purpose of the Study:

  • To enhance the antimalarial efficacy of 3-hydroxypyridin-4-one derivatives.
  • To investigate the introduction of basic nitrogen centers for improved targeting to intracellular acidic vacuoles, such as lysosomes.

Main Methods:

  • Synthesis of novel 3-hydroxypyridin-4-one derivatives incorporating basic nitrogen centers.
  • Evaluation of antimalarial activity in vitro.
  • Assessment of cytotoxicity against mammalian cells.

Related Experiment Videos

Main Results:

  • Several synthesized compounds demonstrated superior antimalarial activity compared to parent 3-hydroxypyridin-4-one structures.
  • The modifications aimed at lysosomal targeting did not compromise the non-toxic profile.

Conclusions:

  • Introducing basic nitrogen centers into 3-hydroxypyridin-4-ones enhances their antimalarial potency.
  • These modified compounds represent promising drug candidates for malaria treatment with improved intracellular targeting.